Phase Ii study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma
Pisoni, M.B.; Libretti, A.; Piazza, E.; Vago, G.; Scapaticci, R.; Bianchi, C.; Tomirotti, M.; Scanni, A.; Calzavara, M.P.; Cassani, L.; Scarpazza, G.; Marsoni, S.; Morasca, L.
Cancer Treatment Reports 65(7-8): 731-732
1981
ISSN/ISBN: 0361-5960 PMID: 6788372 Document Number: 178940
Document emailed within 1 workday
Related Documents
Bonomi, P.D.; Pazdur, R.; Stolbach, L.; Mason, B.; Ettinger, D. 1986: Phase Ii trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma Cancer Treatment Reports 70(12): 1447-1448Dombernowsky, P.; Sörenson, S.; Aisner, J.; Hansen, H.H. 1979: Cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase Ii study Cancer Treatment Reports 63(4): 543-545
Vogelzang, N.J.; Bonomi, P.D.; Rossof, A.H.; Wolter, J. 1978: Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma Cancer Treatment Reports 62(10): 1595-1597
Brugarolas, A.; Rivas, A.; Lacave, A.J.; Gonzalez-Palacois, F.; Froufe, A. 1975: 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study Cancer ChemoTherapy Reports 59(5): 1025-1026
Cohen, M.H.; Broder, L.E.; Fossieck, B.E.; Ihde, D.C.; Minna, J.D. 1977: Phase Ii clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma Cancer Treatment Reports 61(3): 489-490
Cusumano, C.L.; Jernigan, J.A.; Waldman, R.H. 1975: Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase i study Journal of the National Cancer Institute 55(2): 275-279
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Carr, B.I.; Rahbar, S.; Doroshow, J.H.; Blayney, D.; Goldberg, D.; Leong, L.; Asmeron, Y. 1987: Fetal hemoglobin gene activation in a phase Ii study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma Cancer Research 47(15): 4199-4201
Izbicki, R.M.; Amer, M.H.; Al-Sarraf, M. 1979: Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase Ii study Cancer Treatment Reports 63(6): 999-1001
Kochnowski, G.; Rozek, G.; Wisńiewski, J. 1976: Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide Wiadomosci Lekarskie 29(4): 270-271
Smith, D.B.; Thatcher, N.; Steward, W.P.; Brear, G.; Carroll, K.B. 1986: A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology 22(4): 435-437
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Weick, J.K.; Rainey, J.M.; Livingston, R.B.; Baker, L.H.; O'Bryan, R.M.; Chen, T.T. 1985: Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study Cancer Treatment Reports 69(6): 583-585
Kane, R.C.; Cohen, M.H.; Broder, L.E.; Bull, M.I.; Creaven, P.J.; Fossieck, B.E. 1975: Phase I-Ii evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma Cancer ChemoTherapy Reports 59(6): 1171-1172
Tosi, P.; Luzi, P.; Leoncini, L.; Sforza, V.; Gotti, G.; Grossi, A. 1983: Scanning electron microscopy in the diagnosis of bronchogenic squamous cell and small cell anaplastic carcinoma Applied Pathology 1(2): 82-88
Gad-el-Mawla, N.; Ziegler, J.L.; Hamza, R.; Elserafi, M.; Khaled, H. 1984: Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder Cancer Treatment Reports 68(2): 419-421
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Murray, N.; Shah, A.; Band, P. 1987: Phase Ii study of lonidamine in patients with small cell carcinoma of the lung Cancer Treatment Reports 71(12): 1283-1284
Bunn, P.A.; Cohen, M.H.; Ihde, D.C.; Fossieck, B.E.; Matthews, M.J.; Minna, J.D. 1977: Advances in small cell bronchogenic carcinoma Cancer Treatment Reports 61(3): 333-342